arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Instil Bio, Inc.

TIL

$7.39 ▲ +0.15 (+2.14%) at close

26 Visible periods

22 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Instil Bio, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $50.1M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -5.0% ↗

FCF / Share $-0.20

Trailing P/E —

Price / Book 0.5x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

26-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-4.20M

↑ +85.1% —

FCF / Share Free cash flow per share

$-0.20

↑ +69.3% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Oct 31, 2020 10-Q ↗	Q2 FY2020 Oct 31, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
EPS Growth YoY (%)	85.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	35.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	43.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-41.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-15.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	8.5% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	66.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	18.2% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	57.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	94.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-20.9% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	69.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-4.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-268.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-30.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-70.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	36.4% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	56.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	23.3% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	50.9% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-112.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	85.1% Excellent ↑ Excellent Improving Year-over-year change in net income	31.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-16.0% Weak ↓ Weak Declining Year-over-year change in net income	-16.0% Weak ↓ Weak Declining Year-over-year change in net income	-16.0% Weak ↓ Weak Declining Year-over-year change in net income	8.0% Fair ↓ Fair Declining Year-over-year change in net income	57.4% Excellent ↓ Excellent Declining Year-over-year change in net income	57.4% Excellent ↑ Excellent Improving Year-over-year change in net income	57.4% Excellent ↑ Excellent Improving Year-over-year change in net income	76.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-5.5% Weak ↓ Weak Declining Year-over-year change in net income	-5.5% Weak ↑ Weak Improving Year-over-year change in net income	-5.5% Weak ↑ Weak Improving Year-over-year change in net income	2.7% Caution ↑ Caution Improving Year-over-year change in net income	-134.0% Weak ↑ Weak Improving Year-over-year change in net income	-134.0% Weak ↑ Weak Improving Year-over-year change in net income	-134.0% Weak ↑ Weak Improving Year-over-year change in net income	-222.1% Weak ↑ Weak Improving Year-over-year change in net income	-465.6% Weak → Weak Stable Year-over-year change in net income	-465.6% Weak Weak Year-over-year change in net income	-465.6% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	69.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	71.0% Excellent Excellent Year-over-year change in free cash flow	—	—	—	66.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	43.1% Excellent Excellent Year-over-year change in free cash flow	—	—	—	24.1% Good Good Year-over-year change in free cash flow	—	—	—	-207.1% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Oct 31, 2020 10-Q ↗	Q2 FY2020 Oct 31, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	—	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.7% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.9% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.5% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.4% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.9% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.9% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
FCF / Net Income (x)	0.32x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.37x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.52x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.15x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.59x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.04x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	0.76x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.39x Good Good Free cash flow relative to reported net income Optimal: > 1x	1.11x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	1.16x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	3.61x Excellent ↓ Excellent Declining Free cash flow relative to reported net income Optimal: > 1x	10.96x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	10.00x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Oct 31, 2020 10-Q ↗	Q2 FY2020 Oct 31, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-5.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-14.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-28.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-18.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	44.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	33.8% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	28.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	50.1% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-3.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	-5.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-3.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-125%)	-7.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-148%)	-23.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-256%)	-21.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-243%)	-19.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-230%)	-7.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-147%)	-13.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-192%)	-12.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-183%)	-11.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-179%)	-5.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-138%)	-24.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-263%)	-19.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-228%)	-18.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-222%)	-14.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-199%)	-13.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-188%)	-11.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-179%)	-10.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-171%)	-10.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-166%)	-3.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-126%)	-3.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-124%)	-3.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-123%)	43.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+189%)	17.9% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+19%)	25.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+70%)	53.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+254%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Oct 31, 2020 10-Q ↗	Q2 FY2020 Oct 31, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Interest Coverage (x)	-5.16x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6.96x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-10.81x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-16.88x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-34.49x Weak Weak Operating income divided by interest expense Optimal: > 5x	-4.29x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-12.09x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-7.52x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-33.31x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-35.57x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-91.90x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-76.24x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-70.20x Weak Weak Operating income divided by interest expense Optimal: > 5x	-177.41x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-5.02M	$-6.64M	$-5.80M	$-7.69M	$-15.37M	$-8.80M	$-6.66M	$-6.78M	$-5.48M	$-9.20M	$-9.13M	$-21.76M	$-27.35M	$-43.72M	$-41.12M	$-42.46M	$-61.47M	$-37.59M	$-20.40M	$-566.73M	$-609.64M	$-241.71M	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Oct 31, 2020 10-Q ↗	Q2 FY2020 Oct 31, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$0.00	$0.00	$0.00	—	$0.06	$0.05	$0.07	—
Basic EPS, GAAP (USD)	$-0.62	$-1.17	$-2.01	$-3.24	$-4.32	$-1.82	$-3.54	$-2.29	$-3.74	$-1.99	$-10.40	$-2.80	$-8.80	$-33.15	$-8.60	$-9.20	$-8.40	$-9.00	$-6.60	$-5.40	$-13.20	$-20.80	$-8.60	$-11.00	$-6.20	—
Free Cash Flow per Share (USD)	$-0.20	—	$-1.56	$-2.24	$-0.64	—	—	—	$-2.21	—	—	—	$-6.63	—	—	—	$-11.66	—	—	—	$-15.36	—	$-52.97	$-48.53	$-5.00	—
Book Value per Share (USD)	$16.32	$16.79	$17.76	$19.50	$22.09	$25.96	$27.02	$29.98	$31.65	$34.72	$35.98	$45.59	$47.84	$55.91	$63.29	$70.76	$78.71	$86.06	$93.35	$98.72	$103.33	$-38.46	$-26.96	$-19.00	$-11.86	—
Tangible Book Value per Share (USD)	$16.32	$16.79	$17.76	$19.50	$22.09	$25.96	$27.02	$29.98	$31.65	$34.72	$35.98	$45.59	$47.84	$55.91	$62.41	$69.87	$77.83	$85.17	$92.46	$97.83	$102.44	$-44.02	$-26.96	$-19.00	$-20.67	—
Basic Weighted Avg Shares (shares)	6.78M	—	6.76M	6.60M	6.53M	—	6.51M	6.50M	6.50M	—	6.50M	6.50M	6.50M	—	6.48M	6.47M	6.46M	—	6.44M	6.44M	1.75M	—	846,442	842,328	649,868	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Oct 31, 2020 10-Q ↗	Q2 FY2020 Oct 31, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$183.58M	$186.59M	$190.57M	$193.53M	$212.03M	$116.57M	$122.29M	$144.64M	$149.68M	$150.20M	$182.16M	$202.21M	$213.43M	$236.59M	$271.56M	$324.46M	$353.92M	$422.66M	$491.00M	$550.62M	$596.43M	$232.86M	—	—	—	—
Total Equity (USD)	$110.70M	$113.87M	$120.42M	$131.67M	$144.91M	$169.44M	$176.33M	$195.02M	$205.83M	$225.83M	$234.02M	$296.52M	$311.15M	$363.61M	$410.59M	$458.33M	$508.56M	$555.20M	$601.42M	$635.47M	$665.15M	$-39.60M	$-22.82M	$-16.00M	$-7.71M	$-6.89M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Oct 31, 2020 10-Q ↗	Q2 FY2020 Oct 31, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$0.00	$0.00	$0.00	$0.00	$52.00K	$42.00K	$44.00K	—
Depreciation Expense (USD)	$12.00K	$12.00K	$12.00K	$12.00K	$498.00K	$741.00K	$900.00K	$1.00M	$993.00K	$1.04M	$1.00M	$1.00M	$1.78M	$2.10M	$1.90M	$1.00M	$899.00K	$893.00K	$800.00K	$700.00K	$439.00K	$148.00K	$67.00K	$34.00K	$7.00K	—
Net Income, GAAP (USD)	$-4.20M	$-8.19M	$-28.20M	$-28.20M	$-28.20M	$-11.89M	$-24.30M	$-24.30M	$-24.30M	$-12.93M	$-57.07M	$-57.07M	$-57.07M	$-53.84M	$-54.12M	$-54.12M	$-54.12M	$-55.35M	$-23.13M	$-23.13M	$-23.13M	$-17.18M	$-4.09M	$-4.09M	$-4.09M	—
Operating Cash Flow (USD)	$-1.34M	$-7.08M	$-10.56M	$-14.79M	$-4.20M	$-10.56M	—	—	$-14.39M	$-13.38M	—	—	$-34.66M	$-36.98M	—	—	$-55.05M	$-42.79M	—	—	$-17.73M	$-16.82M	$-7.24M	$-3.28M	$-2.28M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters

Instil Bio, Inc.

Analytical Summary

26-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare TIL with peers